{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T08:29:18Z","timestamp":1786350558843,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00415-026-13990-z","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:22:27Z","timestamp":1784139747000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anti-NMDA receptor encephalitis outcomes in a population-based cohort"],"prefix":"10.1007","volume":"273","author":[{"given":"Viridiana","family":"Hernandez-Lopez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica B.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Alsalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Jason N.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn B.","family":"Schwarzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakar","family":"Budhathoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6891-7147","authenticated-orcid":false,"given":"Annette","family":"Langer-Gould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"issue":"12","key":"13990_CR1","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M et al (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7(12):1091\u20131098. https:\/\/doi.org\/10.1016\/S1474-4422(08)70224-2","journal-title":"Lancet Neurol"},{"key":"13990_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4299791","author":"Y Liu","year":"2022","unstructured":"Liu Y, Tian Y, Guo R, Xu X, Zhang M, Li Z et al (2022) Anti-NMDA receptor encephalitis: retrospective analysis of 15 cases, literature review, and implications for gynecologists. J Healthc Eng. https:\/\/doi.org\/10.1155\/2022\/4299791","journal-title":"J Healthc Eng"},{"issue":"12","key":"13990_CR3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000210109","volume":"103","author":"J Brenner","year":"2024","unstructured":"Brenner J, Ruhe CJ, Kulderij I, Bastiaansen AEM, Crijnen YS, Kret CN et al (2024) Long-term cognitive, functional, and patient-reported outcomes in patients with anti-NMDAR encephalitis. Neurology 103(12):e210109. https:\/\/doi.org\/10.1212\/WNL.0000000000210109","journal-title":"Neurology"},{"issue":"6","key":"13990_CR4","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001088","volume":"8","author":"FS Thaler","year":"2021","unstructured":"Thaler FS, Zimmermann L, Kammermeier S, Strippel C, Ringelstein M, Kraft A et al (2021) Rituximab treatment and long-term outcome of patients with autoimmune encephalitis: real-world evidence from the GENERATE registry. Neurol Neuroimmunol Neuroinflamm 8(6):e1088. https:\/\/doi.org\/10.1212\/NXI.0000000000001088","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"13990_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, Armangu\u00e9 T, Glaser C, Iizuka T et al (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12(2):157\u2013165. https:\/\/doi.org\/10.1016\/S1474-4422(12)70310-1","journal-title":"Lancet Neurol"},{"issue":"4","key":"13990_CR6","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T et al (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15(4):391\u2013404. https:\/\/doi.org\/10.1016\/S1474-4422(15)00401-9","journal-title":"Lancet Neurol"},{"issue":"3","key":"13990_CR7","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200552","volume":"13","author":"I Elosua-Bayes","year":"2026","unstructured":"Elosua-Bayes I, Dumez P, Benaiteau M, Ciano-Petersen NL, Farina A, Villagr\u00e1n-Garc\u00eda M et al (2026) Clinical features and biomarkers associated with intensive care-dependent refractory NMDAR encephalitis: a retrospective cohort study. Neurol Neuroimmunol Neuroinflamm 13(3):e200552. https:\/\/doi.org\/10.1212\/NXI.0000000000200552","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"13990_CR8","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ana.25421","volume":"85","author":"JA Lim","year":"2019","unstructured":"Lim JA, Lee ST, Moon J, Jun JS, Kim TJ, Shin YW et al (2019) Development of the clinical assessment scale in autoimmune encephalitis. Ann Neurol 85(3):352\u2013358. https:\/\/doi.org\/10.1002\/ana.25421","journal-title":"Ann Neurol"},{"issue":"4","key":"13990_CR9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000208019","volume":"102","author":"A Morgan","year":"2024","unstructured":"Morgan A, Li Y, Thompson NR, Milinovich A, Abbatemarco JR, Cohen JA et al (2024) Longitudinal disability, cognitive impairment, and mood symptoms in patients with anti-NMDA receptor encephalitis. Neurology 102(4):e208019. https:\/\/doi.org\/10.1212\/WNL.0000000000208019","journal-title":"Neurology"},{"issue":"7","key":"13990_CR10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s004310050658","volume":"156","author":"M Koskiniemi","year":"1997","unstructured":"Koskiniemi M, Koskiniemi M, Mustonen K, Rantala H, Muttilainen M, Herrg\u00e5rd E et al (1997) Epidemiology of encephalitis in children. A prospective multicentre study. Eur J Pediatr 156(7):541\u2013545. https:\/\/doi.org\/10.1007\/s004310050658","journal-title":"Eur J Pediatr"},{"issue":"3","key":"13990_CR11","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1007\/s00415-021-10738-9","volume":"269","author":"MS Nissen","year":"2022","unstructured":"Nissen MS, \u00d8rvik MS, Nilsson AC, Ryding M, Lydolph M, Blaabjerg M (2022) NMDA-receptor encephalitis in Denmark from 2009 to 2019: a national cohort study. J Neurol 269(3):1618\u20131630. https:\/\/doi.org\/10.1007\/s00415-021-10738-9","journal-title":"J Neurol"},{"issue":"1","key":"13990_CR12","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/ana.25131","volume":"83","author":"D Dubey","year":"2018","unstructured":"Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon VA et al (2018) Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol 83(1):166\u2013177. https:\/\/doi.org\/10.1002\/ana.25131","journal-title":"Ann Neurol"},{"issue":"4","key":"13990_CR13","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200255","volume":"11","author":"S Alsalek","year":"2024","unstructured":"Alsalek S, Schwarzmann KB, Budhathoki S, Hernandez-Lopez V, Smith JB, Li BH et al (2024) Racial and ethnic disparities in the incidence of anti-NMDA receptor encephalitis. Neurol Neuroimmunol Neuroinflamm 11(4):e200255. https:\/\/doi.org\/10.1212\/NXI.0000000000200255","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"11","key":"13990_CR14","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","volume":"18","author":"J Dalmau","year":"2019","unstructured":"Dalmau J, Armangu\u00e9 T, Planagum\u00e0 J, Radosevic M, Mannara F, Leypoldt F et al (2019) An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol 18(11):1045\u20131057. https:\/\/doi.org\/10.1016\/S1474-4422(19)30244-3","journal-title":"Lancet Neurol"},{"key":"13990_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.915352","volume":"13","author":"H Zhou","year":"2022","unstructured":"Zhou H, Deng Q, Yang Z, Tai Z, Liu K, Ping Y et al (2022) Performance of the clinical assessment scale for autoimmune encephalitis in a pediatric autoimmune encephalitis cohort. Front Immunol 13:915352. https:\/\/doi.org\/10.3389\/fimmu.2022.915352","journal-title":"Front Immunol"},{"issue":"11","key":"13990_CR16","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1001\/jamaneurol.2021.3188","volume":"78","author":"M Nosadini","year":"2021","unstructured":"Nosadini M, Eyre M, Molteni E, Thomas T, Irani SR, Dalmau J et al (2021) Use and safety of immunotherapeutic management of N-methyl-d-aspartate receptor antibody encephalitis: a meta-analysis. JAMA Neurol 78(11):1333\u20131344. https:\/\/doi.org\/10.1001\/jamaneurol.2021.3188","journal-title":"JAMA Neurol"},{"key":"13990_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2025.578651","volume":"405","author":"Y Hoshina","year":"2025","unstructured":"Hoshina Y, Smith TL, Mstat AD, Wong KH, Peterson LK, Zekeridou A et al (2025) An updated, comprehensive meta-analysis of the treatment of anti-NMDAR encephalitis: analysis, equipoise, and the urgent need for evidence over anecdote. J Neuroimmunol 405:578651. https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578651","journal-title":"J Neuroimmunol"},{"issue":"4","key":"13990_CR18","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200421","volume":"12","author":"NL Ciano-Petersen","year":"2025","unstructured":"Ciano-Petersen NL, Villagr\u00e1n-Garc\u00eda M, Mu\u00f1iz-Castrillo S, Farina A, Vogrig A, Goncalves D et al (2025) Relapses in anti-NMDAR encephalitis: clinical characterization and predictive features. Neurol Neuroimmunol Neuroinflamm 12(4):e200421. https:\/\/doi.org\/10.1212\/NXI.0000000000200421","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"13990_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.104697","volume":"74","author":"Q Wu","year":"2023","unstructured":"Wu Q, Xie Q, Liu L, Meng C, Wang J (2023) Factors influencing prognosis and relapse in patients with anti-N-methyl-D-aspartate receptor encephalitis. Mult Scler Relat Disord 74:104697. https:\/\/doi.org\/10.1016\/j.msard.2023.104697","journal-title":"Mult Scler Relat Disord"},{"issue":"11","key":"13990_CR20","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1007\/s10072-021-05174-6","volume":"42","author":"P Raja","year":"2021","unstructured":"Raja P, Shamick B, Nitish LK, Holla VV, Pal PK, Mahadevan A et al (2021) Clinical characteristics, treatment and long-term prognosis in patients with anti-NMDAR encephalitis. Neurol Sci 42(11):4683\u20134696. https:\/\/doi.org\/10.1007\/s10072-021-05174-6","journal-title":"Neurol Sci"},{"key":"13990_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2147\/PROM.S411260","volume":"14","author":"Z Gong","year":"2023","unstructured":"Gong Z, Lao D, Huang F, Lv S, Mao F, Huang W (2023) Risk factors and prognosis in anti-NMDA receptor encephalitis patients with disturbance of consciousness. Patient Relat Outcome Meas 14:181\u2013192. https:\/\/doi.org\/10.2147\/PROM.S411260","journal-title":"Patient Relat Outcome Meas"},{"issue":"1","key":"13990_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","volume":"10","author":"J Dalmau","year":"2011","unstructured":"Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10(1):63\u201374. https:\/\/doi.org\/10.1016\/S1474-4422(10)70253-2","journal-title":"Lancet Neurol"},{"issue":"4","key":"13990_CR23","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/ane.12723","volume":"136","author":"X Chi","year":"2017","unstructured":"Chi X, Wang W, Huang C, Wu M, Zhang L, Li J et al (2017) Risk factors for mortality in patients with anti-NMDA receptor encephalitis. Acta Neurol Scand 136(4):298\u2013304. https:\/\/doi.org\/10.1111\/ane.12723","journal-title":"Acta Neurol Scand"},{"issue":"7","key":"13990_CR24","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/cid\/cir1038","volume":"54","author":"MS Gable","year":"2012","unstructured":"Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA (2012) The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis 54(7):899\u2013904. https:\/\/doi.org\/10.1093\/cid\/cir1038","journal-title":"Clin Infect Dis"},{"issue":"11","key":"13990_CR25","doi-asserted-by":"publisher","first-page":"5423","DOI":"10.1007\/s10072-024-07642-1","volume":"45","author":"E Soellradl","year":"2024","unstructured":"Soellradl E, von Oertzen TJ, Wagner JN (2024) Evaluation of the clinical assessment scale for autoimmune encephalitis (CASE) in a retrospective cohort and a systematic review. Neurol Sci 45(11):5423\u20135428. https:\/\/doi.org\/10.1007\/s10072-024-07642-1","journal-title":"Neurol Sci"},{"key":"13990_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.796965","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Tu E, Yao C, Liu J, Lei Q, Lu W (2021) Validation of the clinical assessment scale in autoimmune encephalitis in Chinese patients. Front Immunol 12:796965. https:\/\/doi.org\/10.3389\/fimmu.2021.796965","journal-title":"Front Immunol"},{"issue":"2","key":"13990_CR27","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s40120-021-00278-9","volume":"10","author":"MT Cai","year":"2021","unstructured":"Cai MT, Lai QL, Zheng Y, Fang GL, Qiao S, Shen CH et al (2021) Validation of the clinical assessment scale for autoimmune encephalitis: a multicenter study. Neurol Ther 10(2):985\u20131000. https:\/\/doi.org\/10.1007\/s40120-021-00278-9","journal-title":"Neurol Ther"},{"key":"13990_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1490804","volume":"15","author":"Y He","year":"2024","unstructured":"He Y, Li F, Yang A, Yu C, Wang Y, Zhao J et al (2024) Validation of the clinical assessment scale for autoimmune encephalitis in a severe autoimmune encephalitis cohort. Front Immunol 15:1490804. https:\/\/doi.org\/10.3389\/fimmu.2024.1490804","journal-title":"Front Immunol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13990-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13990-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13990-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T07:49:21Z","timestamp":1786348161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13990-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["13990"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13990-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"2 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Annette Langer-Gould receives grant support from the National Institutes of Health. Atara Biotherapeutics provided, and Sanofi-Aventis provides funding to her institution for participating in randomized controlled trials for which she is the site PI. She received no salary support or other compensation from Sanofi-Aventis or Atara Biotherapeutics. She currently serves as a voting member on the California Technology Assessment Forum, a core program of the Institute for Clinical and Economic Review (ICER). Viridiana Hernandez-Lopez reports no disclosures relevant to the manuscript. Jessica B. Smith reports no disclosures relevant to the manuscript. Samir Alsalek reports no disclosures relevant to the manuscript. Fernando Torres reports no disclosures relevant to the manuscript. Jason N. Scott Jr reports no disclosures relevant to the manuscript. Kathryn B. Schwarzmann reports no disclosures relevant to the manuscript. Sakar Budhathoki reports no disclosures relevant to the manuscript. Annette Langer-Gould had full acess to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Annette Langer-Gould had full acess to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"462"}}